> Which is all probably already the case. Remember - my comments about policy were a response to this: > It probably makes more sense if we view the FDA not a

> Which is all probably already the case. Remember - my comments about policy were a response to this: > It probably makes more sense if we view the FDA not as a monolith but a collection of lots of individuals, some of which don't communicate or work together directly. The comment I was replying to implied that the discrepancy was simply due to disparate groups of people not in communication. Your view now seems to be the opposite - it is that they are in communication, and have a policy but that subject matter is complex and will legitimately generate the range of responses we see.